Medically induced abortion at 12 to 22 weeks gestation: Indications, methods, and results


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To give an update on abortion procedures in the second trimester of pregnancy (at 12 to 22 weeks’ gestation). Subject and methods. Available literature sources published in Medline, Pubmed, and other databases were sought. A total of 107 sources dealing with different abortion procedures in the second trimester were found; 20 of them were included in this review. Results. Both surgical (dilatation and evacuation) and medical procedures are recommended to end pregnancy after 12 weeks. Their advantages, high efficiency, and possible complications of the medical procedure using mifepristone and misoprostol over other techniques are shown. Conclusion. The clinical experience of medically induced abortion in late periods (in the second trimester - at 12 to 22 weeks’ gestation) demonstrates that this technique is promising and safe.

Full Text

Restricted Access

About the authors

Natalia E. Kan

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: kan-med@mail.ru
PhD, MD, the head of the obstetric observation department

Igor I. Baranov

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: i_baranov@oparina4.ru
PhD, MD, the head of the organizational-methodological department

Galina B. Dikke

Peoples' Friendship University of Russia

Email: galadikke@yandex.ru
PhD, MD, professor of obstetrics, gynecology and reproductive medicine faculty of postgraduate education of health professionals

Victor L. Tyutyunnik

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: tioutiounnik@mail.ru
PhD, MD, the head of the obstetric physiological department

References

  1. Основные показатели здоровья матери и ребенка, деятельность службы охраны детства и родовспоможения в Российской Федерации. М.; 2014. [Key indicators of maternal and child health, child welfare service activities and obstetrics in the Russian Federation. M., 201. (in Russian)]
  2. О материнской смертности в Российской Федерации в 2012 году. Методическое письмо Минздравсоцразвития РФ от 19.09.2013 г. № 15-4/10/2-7065. 37с. [The maternal mortality rate in the Russian Federation in 2012: Methodical letter to the Health Ministry of the Russian Federation of 09.19.2013 № 15-4/10/37 2-7065. 37 p. (in Russian)]
  3. Andersson I.M., Benson L., Christensson K., Gemzell-Danielsson K. Paracervical block as pain treatment during second-trimester medical termination of pregnancy: an RCT with bupivacaine versus sodium chloride. Hum. Reprod. 2016; 31(1): 67-74.
  4. European Medicines Agency in 2007. Summary of the thirteenth annual report of the EMEA. Available at: http://www.ema.europa.eu
  5. Дикке Г.Б., Сахаутдинова И.В. Современные методы прерывания беременности в поздние сроки. Акушерство и гинекология. 2014; 1: 83-8. [Dikke GB, Sakhautdinova IV. Modern methods of abortion in the later stages. Obstetrics and gynecology. 2014; 1: 83-8. (in Russian)]
  6. ACOG. A Clinician’s Guide to Medical and Surgical Abortion. NAF’s textbook. 2012.
  7. Приказ Министерства здравоохранения Российской Федерации от 01.11.2012г. №572-н «Порядок оказания медицинской помощи по профилю «Акушерство и гинекология» (за исключением использования вспомогательных репродуктивных технологий). [Order of the Ministry of Health of the Russian Federation of 01.11.2012 №572-n «The order of medical care on the profile of Obstetrics and Gynecology» (except for the use of assisted reproductive technology). (in Russian)]
  8. Серов В.Н., Сухих Г.Т., ред. Клинические рекомендации. Акушерство и гинекология. 4-е изд. М.: ГЭОТАР-Медиа; 2014. 1024с. [Serov V.N., Sukhikh G.T., eds. Clinical guidelines. Obstetrics and gynecology. 4th ed. Moscow: GEOTAR-Media; 2014. 1024 p. (in Russian)]
  9. Cheng L. Surgical versus medical methods for induced abortion during the second trimester: RHL commentary (last revised: September 28, 2011). WHO Reproductive Health Library; Geneva: World Health Organization.
  10. Royal College of Obstetricians and Gynaecologists (RCOG). The care of women requesting induced abortion. London (England): Royal College of Obstetricians and Gynaecologists (RCOG); 2011, Nov. 130p.
  11. Rowlands S., Gemzell-Danielsson K., Aubеny E., Fiala C. International Federation for Professionals in Abortion and Contraception (FIAPAC). J. Fam. Plann. Reprod. Health Care. 2011; 37(4): 251-2.
  12. Gemzell-Danielsson K., Lalitkumar S. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Reprod. Health Matters. 2008; 16(31, Suppl.): 162-72.
  13. World Health Organization. Safe abortion: technical and policy guidance for health systems. 2nd ed. Geneva: WHO; 2012. 123p.
  14. Al R.A., Yapca O.E. Vaginal misoprostol compared with buccal misoprostol for termination of second-trimester pregnancy: a randomized controlled trial. Obstet. Gynecol. 2015; 126(3): 593-8.
  15. Goldberg A.B., Fortin J.A., Drey E.A., Dean G., Lichtenberg E.S., Bednarek P.H. et al. Cervical preparation before dilation and evacuation using adjunctive misoprostol or mifepristone compared with overnight osmotic dilators alone: a randomized controlled trial. Obstet. Gynecol. 2015; 126(3): 599-609.
  16. Kelly T., Suddes J., Howel D., Hewison J., Robson S. Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial. BJOG. 2010; 117(12): 1512-20.
  17. Kapp N., Lohr P.A., Ngo T.D., Hayes J.L. Cervical preparation for first trimester surgical abortion. Cochrane Database Syst. Rev. 2010; (2): CD007207.
  18. Ouerdiane N., Othmani K., Daaloul W., Ben Hamouda S., Bouguerra B. Efficacy of misoprostol for medical termination of pregnancy in second trimester: prospective study. Tunis. Med. 2015; 93(4): 212-6.
  19. Ramesh S., Roston A., Zimmerman L., Patel A., Lichtenberg E.S., Chor J. Misoprostol 1 to 3 h preprocedure vs. overnight osmotic dilators prior to early second-trimester surgical abortion. Contraception. 2015; 92(3): 234-40.
  20. Chen Y.P., Wang P.H., Tsui K.H. Comment on the combination of mifepristone and misoprostol for the termination of second-trimester pregnancy. Taiwan J. Obstet. Gynecol. 2015; 54(4): 469-70.
  21. Andersson I.M., Christensson K., Gemzell-Danielsson K. Experiences, feelings and thoughts of women undergoing second trimester medical termination of pregnancy. PLoS One. 2014; 9(12): e115957.
  22. Mark A.G., Wolf M., Edelman A., Castleman L. What can obstetrician/ gynecologists do to support abortion access? Int. J. Gynaecol. Obstet. 2015; 131(Suppl. 1): S53-5.
  23. Nautiyal D., Mukherjee K., Perhar I., Banerjee N. Comparative study of misoprostol in first and second trimester abortions by oral, sublingual, and vaginal routes. J. Obstet. Gynaecol. India. 2015; 65(4): 246-50.
  24. Yazdani S.H., Zeinalzadeh M., Bouzari Z., Golsorkhtabar-Amiri M. Effects of vaginal versus oral misoprostol to terminate second-trimester pregnancy. Clin. Exp. Obstet. Gynecol. 2012; 39(4): 529-31.
  25. Ting W.H., Peng F.H., Lin H.H., Lu H.F., Hsiao S.M. Factors influencing the abortion interval of second trimester pregnancy termination using misoprostol. Taiwan J. Obstet. Gynecol. 2015; 54(4): 408-11.
  26. Tanha F.D., Golgachi T., Niroomand N., Ghajarzadeh M., Nasr R. Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial. Arch. Gynecol. Obstet. 2013; 287(1): 65-9.
  27. Sakkas E.G., Detriche O., Buxant F. Rare complication of a late abortion: a case report. Rev. Med. Brux. 2014; 35(6): 504-6.
  28. Safe abortion: technical and policy guidance for health systems. 2nd ed. World Health Organization, Department of Reproductive Health and Research; 2012.
  29. Mark A.G., Edelman A., Borgatta L. Second-trimester postabortion care for ruptured membranes, fetal demise, and incomplete abortion. Int. J. Gynaecol. Obstet. 2015; 129(2): 98-103.
  30. Sagiv R., Mizrachi Y., Glickman H., Kerner R., Keidar R., Bar J., Golan A. Laminaria vs. vaginal misoprostol for cervical preparation before second-trimester surgical abortion: a randomized clinical trial. Contraception. 2015; 91(5): 406-11.
  31. Lederle L., Steinauer J.E., Montgomery A., Aksel S., Drey E.A., Kerns J.L. Obesity as a risk factor for complications after second-trimester abortion by dilation and evacuation. Obstet. Gynecol. 2015; 126(3): 585-92.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies